Investing.com - Applied Therapeutics (NASDAQ: APLT) reported first quarter EPS of $-0.40, $0.18 worse than the analyst estimate of $-0.22. Revenue for the quarter came in at $0.00 versus the consensus estimate of $0.00.
Applied Therapeutics's stock price closed at $6.17. It is up 98.39% in the last 3 months and up 523.23% in the last 12 months.
Applied Therapeutics saw 1 positive EPS revisions and 1 negative EPS revisions in the last 90 days. See Applied Therapeutics's stock price’s past reactions to earnings here.
According to InvestingPro, Applied Therapeutics's Financial Health score is "good performance".
Check out Applied Therapeutics's recent earnings performance, and Applied Therapeutics's financials here.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar